New CREDENCE Data Support SGLT2 Inhibitor Use in Advanced CKD New CREDENCE Data Support SGLT2 Inhibitor Use in Advanced CKD

' We would not recommend initiating treatment with SGLT2 inhibitor in eGFR
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news